American International Group’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-17,141
Closed -$79K 3219
2019
Q1
$79K Sell
17,141
-557
-3% -$2.64K ﹤0.01% 2725
2018
Q4
$62K Sell
17,698
-136
-0.8% -$945 ﹤0.01% 2814
2018
Q3
$180K Buy
17,834
+321
+2% +$2.56K ﹤0.01% 2495
2018
Q2
$127K Buy
17,513
+1,904
+12% +$13.3K ﹤0.01% 2654
2018
Q1
$94K Sell
15,609
-573
-4% -$4.73K ﹤0.01% 2692
2017
Q4
$156K Buy
16,182
+77
+0.5% +$504 ﹤0.01% 2471
2017
Q3
$143K Buy
16,105
+1,204
+8% +$12.4K ﹤0.01% 2471
2017
Q2
$188K Buy
14,901
+439
+3% +$5.2K ﹤0.01% 2311
2017
Q1
$152K Buy
14,462
+953
+7% +$10.2K ﹤0.01% 2357
2016
Q4
$124K Sell
13,509
-36
-0.3% -$407 ﹤0.01% 2474
2016
Q3
$160K Buy
13,545
+20
+0.1% +$304 ﹤0.01% 2321
2016
Q2
$175K Sell
13,525
-355
-3% -$5.17K ﹤0.01% 2216
2016
Q1
$222K Sell
13,880
-100
-0.7% -$1.9K ﹤0.01% 2695
2015
Q4
$401K Sell
13,980
-24
-0.2% -$665 ﹤0.01% 2208
2015
Q3
$399K Buy
14,004
+16
+0.1% +$589 ﹤0.01% 2212
2015
Q2
$502K Buy
13,988
+1,426
+11% +$44.4K ﹤0.01% 2179
2015
Q1
$365K Hold
12,562
﹤0.01% 2433
2014
Q4
$265K Sell
12,562
-496
-4% -$9.81K ﹤0.01% 2704
2014
Q3
$253K Sell
13,058
-1,210
-8% -$19K ﹤0.01% 2736
2014
Q2
$223K Buy
14,268
+3,936
+38% +$63.6K ﹤0.01% 2885
2014
Q1
$214K Buy
10,332
+249
+2% +$4.94K ﹤0.01% 2784
2013
Q4
$130K Sell
10,083
-99
-1% -$1.37K ﹤0.01% 3138
2013
Q3
$119K Buy
10,182
+10,134
+21,113% +$83.2K ﹤0.01% 3185
2013
Q2
$221 Buy
+48
New +$176 ﹤0.01% 4590

Other funds holding INSY

American International Group's INSY Position: Q2 2019 in Review

American International Group sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 17,141 shares — an estimated $79K sold.

American International Group first reported a position in INSY in Q2 2013 and held it in 24 quarters. The position peaked at $502K in Q2 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • American International Group reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • American International Group sold 17,141 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $79K.
  • American International Group first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
  • American International Group's Insys Therapeutics, Inc. position peaked at $502K in Q2 2015.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on American International Group's 13F filing for Q2 2019, filed 13 Aug 2019.